Zevia Pbc SEC Filings

Zevia PBC (ZVIA) reported a Form 144 notice indicating a proposed sale of 200,000 shares of Class A common stock. The filing lists Merrill Lynch as broker, an approximate sale date of 11/10/2025, and trading on the NYSE, with an aggregate market value of $528,782.54.

The shares were acquired through vesting of restricted stock unit awards granted under the issuer’s equity compensation plan across multiple dates, matching the 200,000 shares to be sold. The filing notes 67,389,166 shares outstanding.

Zevia PBC reported Q3 2025 results showing higher sales and a narrower loss. Net sales were $40.844 million versus $36.366 million a year ago, with gross profit of $18.617 million. Loss from operations was $2.873 million, and net loss attributable to Zevia PBC was $2.686 million, or $0.04 per share.

For the first nine months, net sales reached $123.391 million (up from $115.591 million), and net loss attributable was $8.609 million versus $14.242 million last year, reflecting improved operating performance after restructuring actions.

Liquidity remained solid with $26.029 million in cash at quarter end and no borrowings outstanding on the $20 million revolving credit facility. The company established an at-the-market equity program of up to $20 million in August 2025 and did not issue shares during the quarter. As of October 31, 2025, there were 67,389,166 Class A shares and 7,614,823 Class B shares outstanding.

Zevia PBC furnished an 8‑K announcing its earnings release for the third quarter ended September 30, 2025. The company made the release available as Exhibit 99.1, dated November 5, 2025.

The information under Item 2.02, including Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act, and is not incorporated by reference unless expressly stated in a future filing. The report was signed by Girish Satya, Chief Financial Officer and Principal Accounting Officer.

Zevia PBC received an Amendment No. 1 to Schedule 13G from Divisadero Street entities, disclosing beneficial ownership of 6,159,362 shares of Class A common stock, representing 9.1% of the class. The filing lists shared voting and dispositive power over 6,159,362 shares and no sole voting or dispositive power.

The securities are directly owned by advisory clients of Divisadero Street Capital Management, LP; among those clients, only Divisadero Street Partners, L.P. may be deemed to beneficially own more than 5% of the class. The certification states the holdings were not acquired and are not held for the purpose of changing or influencing control of Zevia.

Divisadero Street Capital Management, LP and affiliates filed Amendment No. 1 to Schedule 13G reporting a significant stake in Zevia PBC (ZVIA). The group, including William Zolezzi, Divisadero Street Partners, L.P., Divisadero Street Partners GP, LLC, and Divisadero Street Capital, LLC, reported beneficial ownership of 6,159,362 shares of Class A Common Stock, representing 9.1% of the class as of the event date 09/30/2025.

The reporting persons disclosed 0 shares with sole voting and dispositive power and 6,159,362 shares with shared voting and dispositive power. All securities are directly owned by advisory clients of Divisadero Street Capital Management, LP; among those clients, only Divisadero Street Partners, L.P. may hold more than 5% of the class. They certified the holdings were not acquired or held to change or influence control.

CDP Investissements Inc. and Caisse de depot et placement du Que9bec amended their Schedule 13D for Zevia PBC Class A Common Stock to report ownership and related disclosures. CDPI directly beneficially owns 17,050,428 shares, representing approximately 25.3% of the outstanding Class A Common Stock based on 67,318,542 shares outstanding as of August 6, 2025.

The amendment clarifies that CDPQ, through its ownership of CDPI, may be deemed to share voting and dispositive power over those shares. The filing states transactions in the past 60 days are set forth in Annex B and otherwise reports no transactions in the last 60 days.

Zevia PBC (ZVIA) Form 144 notice shows a proposed sale of 2,971,664 Class A shares through BMO Capital Markets on 09/30/2025 on the NYSE, with an aggregate market value of $8,112,642.72. The filing reports total Class A shares outstanding of 67,318,542. The shares were acquired on 12/21/2020 via a purchase of Series E preferred units in Zevia LLC that converted to Class A common stock at the issuer's IPO; the acquisition was paid in cash and the filer received 22,022,092 shares in that transaction. The filer reports no securities sold in the past three months and provides the required Rule 144 attestation.

Zevia PBC filed an 8-K reporting that it posted an Investor Presentation to its investor website on August 25, 2025 and attached the presentation as Exhibit 99.1. The company said it may use the presentation, in whole or in part and possibly modified, in investor and analyst presentations on and after August 26, 2025. The filing states the presentation is summary information to be read with the company’s SEC filings and public announcements and contains forward-looking statements subject to customary cautionary language. The filing also notes the furnished items are not "filed" for certain legal liability purposes.

Zevia PBC entered into an Equity Distribution Agreement to sell up to $20,000,000 of its Class A common stock through Piper Sandler as sales agent in an at-the-market offering. The Agent will receive a commission equal to 3.0% of gross sales and has agreed to use commercially reasonable efforts to sell shares; with the Company’s consent, the Agent may also use other lawful sale methods. All shares offered will be issued under the Company’s existing Form S-3 shelf registration and related prospectus supplements. The Company has no obligation to sell and may suspend sales at any time.

The Company intends to use net proceeds, after commissions and expenses, to purchase newly issued Class A units of Zevia LLC at per-unit prices equal to the per-share offering price and for investments in marketing and sales, growth through acquisitions of businesses or assets, and general corporate purposes including working capital and capital expenditures. The agreement includes customary representations, indemnities and expense reimbursement provisions and may be terminated by either party on prior notice.